NUZ 0.00% 23.0¢ neurizon therapeutics limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-132

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,296 Posts.
    lightbulb Created with Sketch. 6314
    Big Pharma gets , what Big Pharma wants ,,, if you don't take their Premium they just start buying at market rate until they have the lions share and appoint new Board members and dominate the Voting Rights...

    The most certain way that MPL will make it to market is under the wing of one of the incumbent juggernauts , My Pick is Pfizer.. They are in the MND Treatment Space to the tune of $1.2B income from MND per annum ,,, their current Treatment is under serious questioning at the FDA , the Adverse effects are significant and plentiful (3 A4 Pages) including soft tissue bleeding? eyes, nose, gums and anus ... Head aches Nausea +++++++

    MPL 'No Adverse Effects"

    The Market did not really understand the ASX Announcement regarding MPL being manufactured to GMP Grade Quality ,, because it was cloaked in negativity... "Contains Contaminants" which later turned to be additional or redundant preservatives and possibly the sucrose coating was thicker than required...

    PAA MPL Tablets can be run in commercial sized batches , the Tablet is by all purposes "Market Ready" being GMP grade enables the Tablets to be run at multiple manufacturing plants Globally to the exact same standards as are Birth control pills and heart/ blood pressure Tablets..

    Using Pfizer as an example , Pfizer have FDA Vouchers ( cost circa $50m USD) that send them to the top of the processing stack. They have access to 100's of Trial centres so could push MPL through to Total Commercialisation extremely swiftly and be revenueing which is what Big Pharma are all about and making returns to satisfy their SH...

    The Phase I/II data is the NEXUS POINT for MPL , the same Safety and Tolerability Data that enables PAA to move forward to a Phase II/III and unlock ODD as well as future grants from Fight MND is also the same data that will enable MPL to be tested on Covid, 28 Human Cancer s, HVTL-1 +++

    Great to see demand and the thickest Depth I've ever seen here ,,, SH just need to Hold or Place their Shares in the Sales Queue ,, but try to resist selling down to the buyers for the sake of instant gratification $$$ looks to me like we are just warming up ,,, Positive Data from this mid 20's low 30's will propel the SP forward into the serious numbers .. NZT

    For those that are on the other stock awaiting the Phase III Results mid March,,,,, best of luck

    I'm receiving in excess of 150 notifications a day now from the PAA thread ,,, many are fresh to PAA , only noticed PAA on the recent rise as it has been dormant for 4 years ,,,, but shows what an increasing SP and decent messaging can deliver,,,finally
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.